Related references
Note: Only part of the references are listed.Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2012)
Avidity determines T-cell reactivity in abacavir hypersensitivity
Jacqueline Adam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Allopurinol reduces antigen-specific and polyclonal activation of human T cells
Damiyn Perez-Mazliah et al.
FRONTIERS IN IMMUNOLOGY (2012)
Characterization of the Antigen Specificity of T-Cell Clones from Piperacillin-Hypersensitive Patients with Cystic Fibrosis
Sabah El-Ghaiesh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2011)
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Tai-Ming Ko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
Saima Chohan
JOURNAL OF RHEUMATOLOGY (2011)
HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency
Jae-Woo Jung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Cross-Reactivity in Drug Hypersensitivity Reactions to Sulfasalazine and Sulfamethoxazole
Anna Zawodniak et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Pharmacogenetics of drug hypersensitivity
Elizabeth J. Philips et al.
PHARMACOGENOMICS (2010)
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
Sitna Halevy et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
Cutting edge:: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells
Charles J. Kroger et al.
JOURNAL OF IMMUNOLOGY (2007)
Cross-reactivity patterns of T cells specific for iodinated contrast media
Marianne Lerch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The lymphocyte transformation test in the diagnosis of drug hypersensitivity
WJ Pichler et al.
ALLERGY (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Relation between adverse events associated with allopurinol and renal function in patients with gout
J Vázquez-Mellado et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
Share Paper
